Demographics (1)
- SEX - Biological sex (phv00436896.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00436907.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00436906.v1.p1)
- Consent - Consent group as determined by DAC (phv00436895.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00436909.v1.p1)
- IS_TUMOR - Tumor status (phv00436908.v1.p1)
- SAMPLE_ID - Sample ID (phv00436905.v1.p1)
- SAMPLE_ID - Sample ID (phv00436898.v1.p1)
- SEQ_PLATFORM - Method of Sequencing (phv00436910.v1.p1)
- SUBJECT_ID - Subject ID (phv00436899.v1.p1)
- SUBJECT_ID - Subject ID (phv00436894.v1.p1)
- SUBJECT_ID - Subject ID (phv00436897.v1.p1)
- SURVIVAL_POST_DX - Survival post diagnosis with GBM (newly diagnosed GBM) (phv00436902.v1.p1)
- SURVIVAL_POST_PVSRIPO - Survival after PVSRIPO infusion (phv00436901.v1.p1)
- SURVIVAL_STATUS - Survival or not (phv00436900.v1.p1)
- TISSUE_COLLECTION_TIMEPOINT - Time point relative to treatment that tissue was collected (phv00436903.v1.p1)
- TREATMENT_ID - ID used in published study (phv00436904.v1.p1)